Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Organogenesis Holdings (ORGO) Interest Expenses (2017 - 2025)

Organogenesis Holdings has reported Interest Expenses over the past 9 years, most recently at -$236000.0 for Q4 2025.

  • Quarterly results put Interest Expenses at -$236000.0 for Q4 2025, down 286.89% from a year ago — trailing twelve months through Dec 2025 was -$2.3 million (down 247.73% YoY), and the annual figure for FY2025 was -$2.3 million, down 247.73%.
  • Interest Expenses for Q4 2025 was -$236000.0 at Organogenesis Holdings, up from -$415000.0 in the prior quarter.
  • Over the last five years, Interest Expenses for ORGO hit a ceiling of $2.5 million in Q1 2021 and a floor of -$961000.0 in Q1 2025.
  • Median Interest Expenses over the past 5 years was $543000.0 (2022), compared with a mean of $534850.0.
  • Biggest five-year swings in Interest Expenses: soared 1773.33% in 2023 and later plummeted 286.96% in 2025.
  • Organogenesis Holdings' Interest Expenses stood at $853000.0 in 2021, then crashed by 103.52% to -$30000.0 in 2022, then soared by 1773.33% to $502000.0 in 2023, then plummeted by 112.15% to -$61000.0 in 2024, then tumbled by 286.89% to -$236000.0 in 2025.
  • The last three reported values for Interest Expenses were -$236000.0 (Q4 2025), -$415000.0 (Q3 2025), and -$669000.0 (Q2 2025) per Business Quant data.